Pharmaceuticals

Premium

Healthcare

14 March, 2017

Top PE firms eye ChrysCapital's stake in Intas Pharma

Several private equity investors are in the fray for PE firm ChrysCapital Investment Advisors Pvt. Ltd’s stake in Intas Pharmaceuticals ......

Healthcare

14 March, 2017

TA Associates backs pharma products supplier Ideal Cures

Private equity firm TA Associates said on Tuesday it has invested in Mumbai-based Ideal Cures Pvt. Ltd, its second bet ......

Premium

Healthcare

09 March, 2017

Torrent Pharma buying select products of Novartis in India

Ahmedabad-based drugmaker Torrent Pharmaceuticals Ltd has agreed to acquire some of the products of global healthcare company Novartis in India, ......

Healthcare

07 March, 2017

Delhi HC restrains former Ranbaxy promoters to dilute or sell assets

The Delhi High Court, on Monday, directed former promoters of Ranbaxy Laboratories Ltd, Malvinder Mohan Singh and Shivinder Mohan Singh, ......

Healthcare

06 March, 2017

Cipla to sell South African animal health business for $29 mn

Mumbai-headquartered pharmaceutical major Cipla Ltd has agreed to sell its animal health business in South Africa to Ascendis Health Ltd ......

Premium

Healthcare

28 February, 2017

Century Pharma hires banker for fresh fundraise; existing investor to exit

Drugmaker Century Pharmaceuticals Ltd has hired an investment bank as it seeks to raise fresh funds and give a full ......

Premium

Healthcare

27 February, 2017

Cipla hires former Dr. Reddy's exec as general counsel

Mumbai-based generic drugmaker Cipla Ltd has hired a former executive at Dr Reddy’s Laboratories Ltd as its global general counsel ......

Healthcare

20 February, 2017

IFC to make $47.5 mn debt investment in Granules India

International Finance Corporation, the private-sector arm of the World Bank, is planning to provide $47.5 million (Rs 318 crore) in ......

Healthcare

10 February, 2017

Eris Lifesciences files DRHP for IPO; ChrysCap to exit

Ahmedabad-based pharmaceutical firm Eris Lifesciences Pvt. Ltd filed a draft red herring prospectus with the capital markets regulator Securities and ......

Healthcare

10 February, 2017

Aurobindo Pharma buys four biosimilar drugs from TL Biopharmaceutical

Drugmaker Aurobindo Pharma Ltd has bought four biosimilar products from Swiss firm TL Biopharmaceutical AG, marking its entry into the ......